MLEC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Moolec Science SA (MLEC) is not a strong buy for a beginner, long-term investor at this time. While the company shows significant revenue growth, its financials remain weak with negative net income, EPS, and gross margin. Technical indicators are mixed, with bearish moving averages and neutral RSI. Additionally, there are no positive trading trends, news catalysts, or proprietary trading signals to support an immediate buy decision. The lack of recent congress trading data and options data further limits actionable insights.
The MACD is positive and expanding, indicating potential upward momentum. However, the RSI is neutral at 48.177, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upside potential in the short term, with resistance at 10.93 and support at 6.613.
Revenue increased significantly by 948.32% YoY in Q2 2025, indicating strong top-line growth.
Net income remains negative at -$2,427,307, EPS is still in the negative at -9.35, and gross margin dropped significantly to -25.78%. No recent news or trading trends to support a bullish sentiment.
In Q2 2025, revenue increased by 948.32% YoY, net income improved by 36.10% YoY but remains negative, EPS improved by 32.06% YoY but is still negative, and gross margin declined significantly by -133.20% YoY.
No analyst rating or price target changes available for MLEC.
